Clinical Trial Site

Heidelberg 3084

1 studies enrolling now · 3 studies all time

What they study most

ANCA-Associated Vasculitis, Atypical Hemolytic Uremic Syndrome, Cerebral Amyloid Angiopathy

Studies at this site

• A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy — Recruiting now
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed
• Evaluation of Potential Predictors of Disease Progression in Participants With Atypical Hemolytic Uremic Syndrome (aHUS) Including Genetics, Biomarkers, and Treatment — Stopped early